Logo image of BC8.DE

BECHTLE AG (BC8.DE) Stock Fundamental Analysis

Europe - FRA:BC8 - DE0005158703 - Common Stock

38.28 EUR
-0.1 (-0.26%)
Last: 11/21/2025, 2:00:29 PM
Fundamental Rating

5

Taking everything into account, BC8 scores 5 out of 10 in our fundamental rating. BC8 was compared to 72 industry peers in the IT Services industry. BC8 has an excellent financial health rating, but there are some minor concerns on its profitability. While showing a medium growth rate, BC8 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BC8 had positive earnings in the past year.
In the past year BC8 had a positive cash flow from operations.
In the past 5 years BC8 has always been profitable.
Each year in the past 5 years BC8 had a positive operating cash flow.
BC8.DE Yearly Net Income VS EBIT VS OCF VS FCFBC8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

BC8's Return On Assets of 5.29% is fine compared to the rest of the industry. BC8 outperforms 63.89% of its industry peers.
BC8 has a Return On Equity of 11.21%. This is comparable to the rest of the industry: BC8 outperforms 51.39% of its industry peers.
BC8's Return On Invested Capital of 8.37% is in line compared to the rest of the industry. BC8 outperforms 50.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BC8 is in line with the industry average of 11.33%.
Industry RankSector Rank
ROA 5.29%
ROE 11.21%
ROIC 8.37%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
BC8.DE Yearly ROA, ROE, ROICBC8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BC8 has a Profit Margin (3.41%) which is in line with its industry peers.
BC8's Profit Margin has improved in the last couple of years.
The Operating Margin of BC8 (4.91%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BC8 has grown nicely.
The Gross Margin of BC8 (18.01%) is worse than 79.17% of its industry peers.
BC8's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.91%
PM (TTM) 3.41%
GM 18.01%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
BC8.DE Yearly Profit, Operating, Gross MarginsBC8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BC8 is creating value.
Compared to 1 year ago, BC8 has about the same amount of shares outstanding.
The number of shares outstanding for BC8 remains at a similar level compared to 5 years ago.
Compared to 1 year ago, BC8 has an improved debt to assets ratio.
BC8.DE Yearly Shares OutstandingBC8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BC8.DE Yearly Total Debt VS Total AssetsBC8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 4.06 indicates that BC8 is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.06, BC8 belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
BC8 has a debt to FCF ratio of 2.34. This is a good value and a sign of high solvency as BC8 would need 2.34 years to pay back of all of its debts.
BC8 has a better Debt to FCF ratio (2.34) than 72.22% of its industry peers.
BC8 has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BC8 (0.30) is better than 63.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.34
Altman-Z 4.06
ROIC/WACC1.27
WACC6.58%
BC8.DE Yearly LT Debt VS Equity VS FCFBC8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BC8 has a Current Ratio of 1.70. This is a normal value and indicates that BC8 is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.70, BC8 belongs to the best of the industry, outperforming 81.94% of the companies in the same industry.
BC8 has a Quick Ratio of 1.42. This is a normal value and indicates that BC8 is financially healthy and should not expect problems in meeting its short term obligations.
BC8's Quick ratio of 1.42 is fine compared to the rest of the industry. BC8 outperforms 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.42
BC8.DE Yearly Current Assets VS Current LiabilitesBC8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

BC8 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.27%.
Measured over the past 5 years, BC8 shows a small growth in Earnings Per Share. The EPS has been growing by 7.58% on average per year.
Looking at the last year, BC8 shows a decrease in Revenue. The Revenue has decreased by -1.21% in the last year.
BC8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.25% yearly.
EPS 1Y (TTM)-18.27%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%-20.83%
Revenue 1Y (TTM)-1.21%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%0.84%

3.2 Future

The Earnings Per Share is expected to grow by 9.45% on average over the next years. This is quite good.
BC8 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.26% yearly.
EPS Next Y-5.21%
EPS Next 2Y4.4%
EPS Next 3Y6.66%
EPS Next 5Y9.45%
Revenue Next Year3.54%
Revenue Next 2Y5.06%
Revenue Next 3Y5.81%
Revenue Next 5Y6.26%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BC8.DE Yearly Revenue VS EstimatesBC8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BC8.DE Yearly EPS VS EstimatesBC8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.52, which indicates a rather expensive current valuation of BC8.
The rest of the industry has a similar Price/Earnings ratio as BC8.
The average S&P500 Price/Earnings ratio is at 25.07. BC8 is around the same levels.
A Price/Forward Earnings ratio of 18.01 indicates a rather expensive valuation of BC8.
BC8's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 34.08. BC8 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 22.52
Fwd PE 18.01
BC8.DE Price Earnings VS Forward Price EarningsBC8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BC8 indicates a slightly more expensive valuation: BC8 is more expensive than 66.67% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as BC8.
Industry RankSector Rank
P/FCF 14.33
EV/EBITDA 11.1
BC8.DE Per share dataBC8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

BC8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.97
EPS Next 2Y4.4%
EPS Next 3Y6.66%

4

5. Dividend

5.1 Amount

BC8 has a Yearly Dividend Yield of 2.01%. Purely for dividend investing, there may be better candidates out there.
BC8's Dividend Yield is comparable with the industry average which is at 3.84.
BC8's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.01%

5.2 History

The dividend of BC8 is nicely growing with an annual growth rate of 16.00%!
Dividend Growth(5Y)16%
Div Incr Years1
Div Non Decr Years6
BC8.DE Yearly Dividends per shareBC8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

BC8 pays out 41.25% of its income as dividend. This is a bit on the high side, but may be sustainable.
BC8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP41.25%
EPS Next 2Y4.4%
EPS Next 3Y6.66%
BC8.DE Yearly Income VS Free CF VS DividendBC8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
BC8.DE Dividend Payout.BC8.DE Dividend Payout, showing the Payout Ratio.BC8.DE Dividend Payout.PayoutRetained Earnings

BECHTLE AG

FRA:BC8 (11/21/2025, 2:00:29 PM)

38.28

-0.1 (-0.26%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-14 2025-11-14
Earnings (Next)N/A N/A
Inst Owners38.17%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap4.82B
Revenue(TTM)6.28B
Net Income(TTM)213.83M
Analysts80
Price Target44.84 (17.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.01%
Yearly Dividend0.7
Dividend Growth(5Y)16%
DP41.25%
Div Incr Years1
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.05%
Min EPS beat(2)-9.37%
Max EPS beat(2)9.48%
EPS beat(4)1
Avg EPS beat(4)-2.98%
Min EPS beat(4)-9.76%
Max EPS beat(4)9.48%
EPS beat(8)2
Avg EPS beat(8)-2.48%
EPS beat(12)4
Avg EPS beat(12)-1.49%
EPS beat(16)7
Avg EPS beat(16)0.63%
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)-0.95%
Revenue beat(4)1
Avg Revenue beat(4)-0.63%
Min Revenue beat(4)-1.25%
Max Revenue beat(4)0.55%
Revenue beat(8)2
Avg Revenue beat(8)-3.48%
Revenue beat(12)5
Avg Revenue beat(12)-0.18%
Revenue beat(16)6
Avg Revenue beat(16)-4.73%
PT rev (1m)0.15%
PT rev (3m)2.94%
EPS NQ rev (1m)2.13%
EPS NQ rev (3m)4.4%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)-7.66%
Revenue NQ rev (1m)-0.88%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)2.03%
Valuation
Industry RankSector Rank
PE 22.52
Fwd PE 18.01
P/S 0.77
P/FCF 14.33
P/OCF 10.93
P/B 2.53
P/tB 5.33
EV/EBITDA 11.1
EPS(TTM)1.7
EY4.44%
EPS(NY)2.13
Fwd EY5.55%
FCF(TTM)2.67
FCFY6.98%
OCF(TTM)3.5
OCFY9.15%
SpS49.81
BVpS15.14
TBVpS7.19
PEG (NY)N/A
PEG (5Y)2.97
Graham Number24.06
Profitability
Industry RankSector Rank
ROA 5.29%
ROE 11.21%
ROCE 11.8%
ROIC 8.37%
ROICexc 10.47%
ROICexgc 20.12%
OM 4.91%
PM (TTM) 3.41%
GM 18.01%
FCFM 5.36%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
ROICexc(3y)15.84%
ROICexc(5y)15.71%
ROICexgc(3y)29.63%
ROICexgc(5y)28.23%
ROCE(3y)16.94%
ROCE(5y)16.89%
ROICexgc growth 3Y4.87%
ROICexgc growth 5Y7.72%
ROICexc growth 3Y-3.54%
ROICexc growth 5Y2.28%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
F-Score4
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.34
Debt/EBITDA 1.26
Cap/Depr 69.05%
Cap/Sales 1.67%
Interest Coverage 13.51
Cash Conversion 95.99%
Profit Quality 157.36%
Current Ratio 1.7
Quick Ratio 1.42
Altman-Z 4.06
F-Score4
WACC6.58%
ROIC/WACC1.27
Cap/Depr(3y)72%
Cap/Depr(5y)67.96%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.35%
Profit Quality(3y)113.31%
Profit Quality(5y)113.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.27%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%-20.83%
EPS Next Y-5.21%
EPS Next 2Y4.4%
EPS Next 3Y6.66%
EPS Next 5Y9.45%
Revenue 1Y (TTM)-1.21%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%0.84%
Revenue Next Year3.54%
Revenue Next 2Y5.06%
Revenue Next 3Y5.81%
Revenue Next 5Y6.26%
EBIT growth 1Y-17.65%
EBIT growth 3Y6.14%
EBIT growth 5Y10.1%
EBIT Next Year36.18%
EBIT Next 3Y17.72%
EBIT Next 5Y12.47%
FCF growth 1Y15.41%
FCF growth 3Y27.55%
FCF growth 5Y27.87%
OCF growth 1Y14.88%
OCF growth 3Y25.19%
OCF growth 5Y24.58%

BECHTLE AG / BC8.DE FAQ

Can you provide the ChartMill fundamental rating for BECHTLE AG?

ChartMill assigns a fundamental rating of 5 / 10 to BC8.DE.


What is the valuation status of BECHTLE AG (BC8.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to BECHTLE AG (BC8.DE). This can be considered as Overvalued.


How profitable is BECHTLE AG (BC8.DE) stock?

BECHTLE AG (BC8.DE) has a profitability rating of 6 / 10.


What is the expected EPS growth for BECHTLE AG (BC8.DE) stock?

The Earnings per Share (EPS) of BECHTLE AG (BC8.DE) is expected to decline by -5.21% in the next year.


How sustainable is the dividend of BECHTLE AG (BC8.DE) stock?

The dividend rating of BECHTLE AG (BC8.DE) is 4 / 10 and the dividend payout ratio is 41.25%.